The FDA has approved Juluca®, the first two-drug regimen for maintenance treatment of HIV infection in adults, with the hope of presenting additional treatment options and lessening the burden on HIV-infected adults.
Browsing: Research > Clinical
Nontuberculous mycobacteria (NTM) are increasingly recognized as important opportunistic pathogens of humans, the authors dicuss the clinical managment and treatments for nontuberculous mycobacterial infections.
Researchers have discovered endemic malaria infection in a geographically-restricted set of wild bonobos, including a possible new species of the parasite.
Continuing our focus on antimicrobial resistance, Editor, Martha Powell, takes a closer look at the steps that can be taken to prevent the spread of drug resistance.
Researchers have unveiled novel pathways controlled by the multiple antibiotic resistance operon and identified new ways in which bacteria protect themselves against antibiotics.
As part of our focus around World Antibiotic Awareness Week (13–19 November) we spoke to Professor Jonathan Cooke, a pharmacologist and pharmacist based in the UK who holds a special interest in antimicrobial resistance. He shares his thoughts on this pressing issue below:
In this review the authors systematically review the association between maternal nutritional status in pregnancy and infant immune response to childhood vaccines.
Take a look at the Storify of our Twitter chat #TalkAMR and catch up on all the great content!
In this infographic we summarize the clinical candidates reported by the WHO – indicating which diseases they are active (or possibly active) against, whether they’re considered innovative and which Phase the trials are currently in.